Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Stemtech (STEK) EBT Margin (2021 - 2025)

Stemtech's EBT Margin history spans 6 years, with the latest figure at 95.34% for Q3 2025.

  • On a quarterly basis, EBT Margin rose 1821.0% to 95.34% in Q3 2025 year-over-year; TTM through Sep 2025 was 79.43%, a 2329.0% increase, with the full-year FY2024 number at 74.65%, up 3572.0% from a year prior.
  • EBT Margin hit 95.34% in Q3 2025 for Stemtech, down from 42.45% in the prior quarter.
  • Over the last five years, EBT Margin for STEK hit a ceiling of 1660.53% in Q3 2022 and a floor of 1956.08% in Q2 2022.
  • Historically, EBT Margin has averaged 114.46% across 5 years, with a median of 75.43% in 2021.
  • The widest YoY moves for EBT Margin: up 224649bps in 2022, down -188065bps in 2022.
  • Tracing STEK's EBT Margin over 5 years: stood at 64.62% in 2021, then soared by 36bps to 41.32% in 2022, then plummeted by -231bps to 136.88% in 2023, then soared by 78bps to 30.19% in 2024, then tumbled by -216bps to 95.34% in 2025.
  • Business Quant data shows EBT Margin for STEK at 95.34% in Q3 2025, 42.45% in Q2 2025, and 168.05% in Q1 2025.